Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD repeat domain 45B pseudogene 1 (WDR45BP1) is classified as a pseudogene; it does not produce a functional protein and lacks known molecular activity or disease relevance. The nomenclature is sometimes confused with WDR45B, a protein-coding gene encoding WD repeat domain 45B, which is involved in autophagy. WDR45BP1 should not be considered a classical drug target or receptor, and there is no substantive evidence for biomarker or therapeutic application.
None (No mechanism of action known for drugs targeting this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD repeat domain 45B pseudogene 1 (WDR45BP1).